Fasted plasma asprosin concentrations are associated with menstrual cycle phase, oral contraceptive use and training status in healthy women

التفاصيل البيبلوغرافية
العنوان: Fasted plasma asprosin concentrations are associated with menstrual cycle phase, oral contraceptive use and training status in healthy women
المؤلفون: Nicolette C. Bishop, Alexandra L. Shill, Amber N. Leonard, Alice E. Thackray, David J. Stensel
المصدر: European Journal of Applied Physiology
بيانات النشر: Springer Berlin Heidelberg, 2020.
سنة النشر: 2020
مصطلحات موضوعية: 0301 basic medicine, Adult, Physiology, Fibrillin-1, 030209 endocrinology & metabolism, Appetite hormone, 03 medical and health sciences, Young Adult, 0302 clinical medicine, Insulin resistance, Sex hormone-binding globulin, Physiology (medical), Orexigenic, Follicular phase, medicine, Birth control, Humans, Orthopedics and Sports Medicine, Exercise, Menstrual Cycle, Progesterone, biology, Estradiol, business.industry, Public Health, Environmental and Occupational Health, General Medicine, Fasting, medicine.disease, Pre-menopausal, Obesity, Polycystic ovary, Menstruation, Menstrual cycle phase, 030104 developmental biology, biology.protein, Original Article, Female, business, medicine.drug, Hormone, Contraceptives, Oral
الوصف: Purpose Asprosin, an orexigenic hormone that stimulates hepatic glucose release, is elevated in insulin resistance and associated with obesity. Plasma asprosin concentrations may also be related to female sex hormone levels; higher levels are reported in women with polycystic ovary syndrome (PCOS) but this may be related to peripheral insulin resistance also associated with PCOS. Clarification of female-specific factors influence on the plasma asprosin response is crucial for studies investigating asprosin. Therefore, this study determined the association of menstrual phase, oral contraceptive (OC) use (as a pharmacological influence on sex hormone levels) and training status (as a physiological influence on sex hormone levels) on plasma asprosin levels in pre-menopausal women. Methods Fasting plasma asprosin, 17β-estradiol (E2) and progesterone, were assessed in 32 healthy untrained and trained women with regular menstrual cycles (non-OC; n = 8 untrained, n = 6 trained) or using OC (n = 10 untrained, n = 8 trained) during early follicular, late follicular and mid-luteal menstrual phases (or the time-period equivalent for OC users). Results Asprosin was lower in OC (0.75 ± 0.38 ng mL−1) than non-OC users (1.00 ± 0.37 ng mL−1; p = 0.022). Across a cycle, asprosin was highest in the early follicular equivalent time-point in OC users (0.87 ± 0.37 ng mL−1) but highest in the mid-luteal phase in non-OC users (1.09 ± 0.40 ng mL−1). Asprosin concentrations varied more across a cycle in untrained than trained women, with higher concentrations in the early follicular phase compared to the late follicular and mid-luteal (training status-by-menstrual phase interaction p = 0.028). Conclusion These findings highlight the importance of considering OC use, menstrual cycle phase and to a lesser extent training status when investigating circulating asprosin concentrations in females.
اللغة: English
تدمد: 1439-6327
1439-6319
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e85bef15062d630e0cdeefd5bbda1d9Test
http://europepmc.org/articles/PMC7892699Test
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....5e85bef15062d630e0cdeefd5bbda1d9
قاعدة البيانات: OpenAIRE